SeaStar Medical
10 hedge funds and large institutions have $1.85M invested in SeaStar Medical in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
25% more funds holding
Funds holding: 8 → 10 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 0.04% → 0.03% (-0.01%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
62% less capital invested
Capital invested by funds: $4.82M → $1.85M (-$2.97M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$59.6K |
| 2 |
State Street
Boston,
Massachusetts
|
+$35.8K |
| 3 |
LPL Financial
San Diego,
California
|
+$34.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$13.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.37K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.27M |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$2.87K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2.55K |
| 4 |
Goldman Sachs
New York
|
-$851 |
| 5 |
Morgan Stanley
New York
|
-$12 |
ICU Hedge Fund Activity: Q1 2023 in Review
10 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q1 2023, worth a combined $1.85M — down 62% from $4.82M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ICU positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Kestra Advisory Services, opening a new position worth an estimated $59.6K. The largest seller was Hudson Bay Capital Management, cutting an estimated $1.27M.
- 10 institutional investors held SeaStar Medical (ICU) as of Q1 2023, up from 8 in Q4 2022.
- Funds reported $1.85M of SeaStar Medical stock for Q1 2023, down 62% quarter-over-quarter.
- 3 funds opened new SeaStar Medical positions in Q1 2023 and 1 closed out, a net change of +2 holders.
- The largest SeaStar Medical buyer in Q1 2023 was Kestra Advisory Services, an estimated $59.6K added.
- The largest SeaStar Medical seller in Q1 2023 was Hudson Bay Capital Management, an estimated $1.27M sold.
Based on aggregated 13F filings for Q1 2023.